Literature DB >> 17657040

Extended spectrum beta lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai.

A Subha1, S Ananthan.   

Abstract

PURPOSE: To examine the incidence of extended spectrum b lactamase (ESbL) producing strains and multidrug resistant strains of Klebsiella pneumoniae isolated from children between 0-5 years of age.
METHODS: Multidrug resistance and ESbL production was studied in a total of 120 isolates of Klebsiella pneumoniae obtained from patients aged 0-5 years.
RESULTS: 95% of the isolates showed resistance or decreased susceptibility to at least one of the three third generation cephalosporins [3GC (ceftazidime, cefotaxime, ceftriaxone)] used for the study. 87% of the isolates showed resistance to all the three 3GC antibiotics and this resistance to all the three 3GC was found to coexist with resistance to other antibiotics. All the isolates were found sensitive to the antibiotic imipenem. ESbL production was detected in 8 strains of Klebsiella pneumoniae. The ESbL activity could be experimentally transferred to recipient E. coli (K12 J62-2). Resistance to b-lactam antibiotics was co-transferred with resistance to gentamicin.
CONCLUSIONS: This study has shown the incidence of ESbL producing Klebsiella pneumoniae strains among children in Chennai. Tests for the detection of ESbL producing Klebsiella strains should be carried out in all diagnostic centers routinely and the therapeutic use of all the 3GC should be avoided against Klebsiella strains that appear resistant to any third generation antibiotic.

Entities:  

Year:  2002        PMID: 17657040

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  10 in total

1.  [(125)I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load.

Authors:  Mrudula Pullambhatla; Jean Tessier; Graham Beck; Bruno Jedynak; Jens U Wurthner; Martin G Pomper
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

2.  Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center.

Authors:  Naveen Grover; A K Sahni; S Bhattacharya
Journal:  Med J Armed Forces India       Date:  2012-07-17

3.  Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin.

Authors:  Dechen C Tsering; Shyamasree Das; Luna Adhiakari; Ranabir Pal; Takhellambam Sk Singh
Journal:  J Glob Infect Dis       Date:  2009-07

4.  First Report of OXA-4, an ESBL Isolated from Pseudomonas aeruginosa a South Indian Strain.

Authors:  S A Jemima Kingsley; Susan Verghese
Journal:  Indian J Microbiol       Date:  2012-10-31       Impact factor: 2.461

5.  Occurrence of Plasmid-Mediated AmpC β-Lactamases Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Tertiary Care Hospital in Bangalore.

Authors:  B Sasirekha; Srividya Shivakumar
Journal:  Indian J Microbiol       Date:  2011-08-11       Impact factor: 2.461

6.  Fact-finding Survey of Nosocomial Infection Control in Hospitals in Kathmandu, Nepal-A Basis for Improvement.

Authors:  Hiroshi Ohara; Bharat M Pokhrel; Rajan K Dahal; Shyam K Mishra; Hari P Kattel; Dharma L Shrestha; Yumiko Haneishi; Jeevan B Sherchand
Journal:  Trop Med Health       Date:  2013-06-29

7.  Detection of Extended Spectrum β-lactamase Production Among Uropathogens.

Authors:  Ritu Aggarwal; Uma Chaudhary; Rama Sikka
Journal:  J Lab Physicians       Date:  2009-01

8.  Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples.

Authors:  Dinesh Kumar; Amit Kumar Singh; Mohammad Rashid Ali; Yogesh Chander
Journal:  Infect Dis (Auckl)       Date:  2014-03-25

9.  Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India.

Authors:  Sunayana Saha; Sridhara Nayak; Indrani Bhattacharyya; Suman Saha; Amit K Mandal; Subhanil Chakraborty; Rabindranath Bhattacharyya; Ranadhir Chakraborty; Octavio L Franco; Santi M Mandal; Amit Basak
Journal:  Front Microbiol       Date:  2014-09-18       Impact factor: 5.640

10.  Antimicrobial Resistance Profile of Different Clinical Isolates against Third-Generation Cephalosporins.

Authors:  Fanta Gashe; Eshetu Mulisa; Mekidim Mekonnen; Gemechu Zeleke
Journal:  J Pharm (Cairo)       Date:  2018-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.